Benchmark Has Lowered Expectations for Enovix (NASDAQ:ENVX) Stock Price

Enovix (NASDAQ:ENVX) had its target price lowered by equities research analysts at Benchmark from $25.00 to $15.00 in a report released on Thursday,Benzinga reports. The firm currently has a “buy” rating on the stock. Benchmark’s price target indicates a potential upside of 145.50% from the company’s current price.

Several other research analysts also recently issued reports on ENVX. JPMorgan Chase & Co. downgraded shares of Enovix from a “neutral” rating to an “underweight” rating in a report on Wednesday, May 6th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Enovix in a report on Friday, April 10th. Craig Hallum reduced their price objective on shares of Enovix from $10.00 to $8.00 and set a “buy” rating on the stock in a research note on Thursday. B. Riley Financial reduced their price objective on shares of Enovix from $17.00 to $10.00 and set a “buy” rating on the stock in a research note on Monday, March 2nd. Finally, Canaccord Genuity Group reduced their price objective on shares of Enovix from $21.00 to $15.00 and set a “buy” rating on the stock in a research note on Thursday, February 26th. Seven investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $12.64.

Enovix Stock Down 3.0%

Shares of NASDAQ:ENVX opened at $6.11 on Thursday. The company has a fifty day moving average of $5.82 and a 200-day moving average of $7.10. The company has a market capitalization of $1.33 billion, a PE ratio of -7.36 and a beta of 2.24. The company has a debt-to-equity ratio of 1.90, a quick ratio of 8.13 and a current ratio of 8.34. Enovix has a 52-week low of $4.61 and a 52-week high of $16.49.

Enovix (NASDAQ:ENVX) last announced its quarterly earnings results on Wednesday, May 13th. The company reported ($0.14) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.15) by $0.01. The company had revenue of $7.60 million during the quarter, compared to the consensus estimate of $6.95 million. Enovix had a negative net margin of 499.64% and a negative return on equity of 63.25%. The company’s revenue for the quarter was up 49.1% compared to the same quarter last year. During the same period in the prior year, the business earned ($0.15) earnings per share. Enovix has set its Q2 2026 guidance at -0.170–0.130 EPS. On average, equities analysts predict that Enovix will post -0.81 EPS for the current fiscal year.

Institutional Trading of Enovix

Several institutional investors have recently modified their holdings of the business. SummitTX Capital L.P. bought a new stake in shares of Enovix in the first quarter worth $167,000. Gateway Wealth Partners LLC bought a new stake in Enovix during the first quarter valued at $68,000. Waverly Advisors LLC boosted its position in Enovix by 51.1% during the first quarter. Waverly Advisors LLC now owns 68,000 shares of the company’s stock valued at $352,000 after acquiring an additional 23,000 shares during the last quarter. Inceptionr LLC bought a new stake in Enovix during the first quarter valued at $501,000. Finally, Cetera Investment Advisers boosted its position in Enovix by 4.3% during the first quarter. Cetera Investment Advisers now owns 195,117 shares of the company’s stock valued at $1,011,000 after acquiring an additional 8,126 shares during the last quarter. Institutional investors own 50.92% of the company’s stock.

Key Stories Impacting Enovix

Here are the key news stories impacting Enovix this week:

• Positive Sentiment: Enovix’s Q1 results beat revenue expectations and the company reported a smaller-than-expected loss, while management highlighted revenue growth and strategic progress on the earnings call. Enovix Corp (ENVX) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic Alignments
• Positive Sentiment: Unusually heavy call option activity suggests some traders are betting on a rebound in Enovix shares. Enovix (NASDAQ:ENVX) Price Target Cut to $21.00 by Analysts at Oppenheimer
• Neutral Sentiment: Oppenheimer, Benchmark, Craig Hallum, and TD Cowen all reduced their price targets on Enovix, but most still kept constructive ratings, signaling lower valuation expectations rather than a full thesis change. Enovix (NASDAQ:ENVX) Given New $15.00 Price Target at Benchmark Enovix (NASDAQ:ENVX) Price Target Lowered to $8.00 at Craig Hallum Enovix (NASDAQ:ENVX) Price Target Cut to $7.00 by Analysts at TD Cowen
• Negative Sentiment: Investors are also focused on Enovix’s widening losses and the uncertain timeline for commercialization, which appeared to weigh on the stock after earnings. Enovix sinks as losses widen; commercialization timeline remains in focus

About Enovix

Enovix Corporation (NASDAQ: ENVX) develops and manufactures advanced lithium-ion battery cells with a patented three-dimensional silicon-anode architecture. The company’s core focus is on delivering high energy density, improved safety, and longer cycle life compared to conventional graphite-based cells. Enovix’s technology targets a range of applications, including consumer electronics, wearable devices, electric vehicles and stationary energy storage systems.

Founded in 2011 and headquartered in Fremont, California, Enovix has built pilot production capability and is scaling up manufacturing capacity to meet growing demand.